Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 14

Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial

Total article views   Abstract views HTML views PDF downloads Totals
5,724 Dovepress* 4,604 725+ 1,370 5,329
PubMed Central* 0 395 167 395
Totals 4,604 1,120 1,537 5,724
*Since 19 September 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
20 2 0 0 8 10

View citations on PubMed Central and Google Scholar